| Name | Address | City |
|---|---|---|
| Addiction Research Foundation | 4126 Autumn Lane | Birmingham |
| Birmingham Metro Treatment Center | 151 Industrial Drive | Birmingham |
| Tri County Treatment Center | 5605 Clifford Circle | Birmingham |
| Walker Recovery Center | 2195 N Airport Rd | Jasper |
| Shelby County Treatment Center | 750 Highway 31 South | Saginaw-Alabaster |
| BHG Bessemer Treatment Center | 4204 Edmonton Drive | Bessemer |
No results found!
Finding opioid use disorder treatment in Birmingham
Birmingham sits at the center of Jefferson County, Alabama’s most populous county, and it has some of the deepest medication treatment capacity in the state. People here can reach both opioid treatment programs that dispense methadone and office-based clinicians who prescribe buprenorphine or naltrexone, and academic medicine at UAB adds emergency-department and outpatient options that many smaller Alabama communities lack. Medications for opioid use disorder (MOUD), the three FDA-approved treatments for opioid use disorder (OUD), are the standard of care. The listings above show programs in and around Birmingham. You can call a provider directly or use the helpline on this page to talk through a first step.
Your medication and setting choices, and where each one comes from
Three medications are approved to treat opioid use disorder, and they are available in two kinds of settings. Understanding the difference tells you what the listings above actually represent.
Methadone is a full opioid agonist that steadies withdrawal and craving. For opioid use disorder it is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy, so dosing starts on site. Buprenorphine, including the buprenorphine-naloxone combination sold as Suboxone and the extended-release monthly injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside an OTP. Since 2023, any clinician with a standard DEA registration can prescribe it, which has widened where you can get care. Naltrexone, including the monthly Vivitrol injection, blocks opioid effects and can be prescribed by any licensed provider, but treatment starts only after you have been off opioids for a set time.
Office-based opioid treatment (OBOT) means a clinician’s office rather than a clinic you attend daily. If you want to weigh the trade-offs, it helps to read how methadone and Suboxone compare and to understand what an opioid treatment program involves before you call. Any of these is a decision to make with a clinician, and no single medication is right for everyone.
Starting treatment: what the first visit looks like
The first step is an intake assessment, where a clinician reviews your history, confirms the diagnosis, and talks through medication options. Bring a photo ID and any insurance information if you have it, though many programs will begin the conversation without it. Some Birmingham programs can start you the same day.
If you have been using fentanyl, timing matters when starting buprenorphine. Taking it too soon after fentanyl can trigger sudden, severe withdrawal, called precipitated withdrawal, so a clinician plans the first dose with you and may use a low-dose approach. This is a normal part of the conversation, not a reason to wait. For more on the medication route, see how treatment works when fentanyl is involved and the broader picture of opioid use disorder treatment.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 expanded access in ways that help people already in treatment or transferring in. Under the revised 42 CFR Part 8, opioid treatment programs can provide take-home methadone up to a 28-day supply for patients who are stable in treatment, on a graduated schedule, and the program decides eligibility based on your progress. The same update allowed treatment to start by telehealth and removed the old requirement of a one-year history of addiction before admission.
As of July 2026, buprenorphine can be started through telehealth, including by phone in many cases, without a prior in-person visit. Those flexibilities run through the end of 2026 and are still being finalized, so confirm what is current with a provider. Methadone for opioid use disorder remains dispensed through an OTP, though some programs can begin treatment with a telehealth visit. If you are transferring or need a guest dose while traveling, ask a program directly, and know that staying consistent with your dose protects the progress you have made.
Paying for treatment in Alabama
Alabama Medicaid covers all three medications for opioid use disorder. In January 2025 the agency launched the first phase of a MOUD initiative that moved opioid-dependence medications into its Electronic Prior Authorization system, so buprenorphine can often be approved at the pharmacy counter without a separate manual review when claims criteria are met (Alabama Medicaid Agency, 2025). Alabama has not expanded Medicaid, so some adults will not qualify, and coverage still depends on eligibility. Private insurance and Medicare cover MOUD as well, and several Birmingham programs offer self-pay or sliding-scale fees. UAB’s Beacon Recovery, for example, sets fees on a sliding scale and states that no one is turned away for inability to pay. Ask each program what it accepts before your first visit.
Overdose deaths are falling in Jefferson County, and why that matters for you
Jefferson County has seen a real, measurable decline in overdose deaths. Fentanyl-related overdose deaths in the county fell from 253 in 2024 to 130 in 2025 (Gulf Coast HIDTA Drug Threat Assessment, 2026), and total overdose deaths dropped to 318 in 2024 from a much higher peak, according to the Jefferson County Coroner’s Office data compiled by the Public Affairs Research Council of Alabama (2025). Officials credit targeted, data-driven outreach: the Jefferson County Department of Health used coroner data mapped by zip code to steer naloxone and outreach into the neighborhoods hit hardest, including Black residents, among whom overdose deaths rose sharply after fentanyl arrived. Fentanyl still drives most opioid deaths statewide, so the drug supply is not safe, but the trend shows that treatment and harm reduction save lives here. If you are worried about yourself or someone else, starting or staying in treatment is the strongest step, and the listings above are a place to begin. You can also read more about opioid use disorder and how it is treated.
Naloxone and staying safe while you decide
Naloxone, the medication that reverses an opioid overdose, is available over the counter and through pharmacies and community programs. In Alabama, the State Health Officer’s standing order lets pharmacies dispense it without an individual prescription, and the state’s Good Samaritan law (HB208) offers limited protection from certain charges for people who call for help during an overdose. The Jefferson County Department of Health mails free naloxone kits and fentanyl test strips to county residents who request them online and stocks dispensing boxes at its health centers and other community sites. Keeping naloxone on hand is worthwhile for anyone using opioids or living with someone who does. If a return to use happens, treat it as a manageable part of a chronic condition, not a failure, and reconnect with care. For more, see how opioid overdose happens and how to respond.
Pregnancy, parenting, and justice-involved care
If you are pregnant and have opioid use disorder, methadone or buprenorphine is the recommended standard of care, because staying in treatment protects both you and the pregnancy. Untreated opioid use carries far higher risks than medication does. Neonatal opioid withdrawal syndrome (NOWS) can be managed by a care team when it is anticipated, and a Plan of Safe Care is meant to coordinate support, not to punish. Fear of child-welfare involvement keeps some pregnant patients from seeking care, so it is worth knowing that treatment is the protective choice; you can start by reading about medication treatment during pregnancy. For people entering treatment through a court, probation, or a hospital referral, Birmingham programs handle these situations routinely and can discuss documentation and confidentiality. Families who want to understand how to help can start with this guide for loved ones.
Common questions about treatment in Birmingham
Is methadone or Suboxone better?
Neither is better for everyone. Methadone is a full agonist dispensed through an opioid treatment program and can suit people who need more structure; buprenorphine (Suboxone) is a partial agonist available in an office and at a pharmacy, with a ceiling effect that lowers overdose risk. The right fit depends on your history and goals, decided with a clinician. Our questions and answers section covers this in more depth.
Do I have to go to a clinic every day?
Not necessarily, and less often than in the past. Methadone starts with more frequent visits, but federal rules updated in 2024 let stable patients earn take-home supplies of up to 28 days. Buprenorphine and naltrexone from an office-based provider do not require daily visits at all.
Can I get treatment the same day?
Sometimes. Some Birmingham programs offer same-day or next-day intake, and buprenorphine can often be started quickly, including by telehealth. Call the programs in the listings above to ask about current availability.
Will treatment become another addiction?
No. Taking methadone or buprenorphine as prescribed is medical treatment for a chronic condition, not a new addiction, and long-term use is legitimate, effective care. You can read more about how methadone works in the body.
What does treatment cost if I have Medicaid?
Alabama Medicaid covers all three medications, and buprenorphine can often be approved at the pharmacy counter without extra paperwork when criteria are met. If you are uninsured, ask programs about sliding-scale fees; some, like UAB Beacon Recovery, do not turn people away for inability to pay.
About this page
Last reviewed July 2026.
Sources:
- Alabama Medicaid Agency, Medications for Opioid Use Disorder (MOUD) initiative and Preferred Drug List updates, 2025.
- Gulf Coast HIDTA / Alabama Department of Public Health, Alabama Drug Threat Assessment, 2026.
- Public Affairs Research Council of Alabama, Jefferson County overdose deaths analysis (Jefferson County Coroner’s Office data), 2025.
- Alabama Department of Public Health, Naloxone and Opioid Overdose Reversal Agents standing order; Alabama Department of Mental Health, Opioid Overdose and Addiction Council, 2024 to 2025.
- Substance Abuse and Mental Health Services Administration (SAMHSA), 42 CFR Part 8 final rule, 2024; DEA and SAMHSA telemedicine rules, 2025 to 2026.
- UAB Center for Addiction and Pain Prevention and Intervention, Beacon Recovery program information, 2025.
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. The information provided is not a substitute for professional treatment advice.
Calls to any general helpline on this site will be answered or returned by a paid advertiser. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.